Dr. Michael B. Morgan, MD

Dr. Morgan practices at OnePath Diagnostics in Jacksonville, Florida.

Dr. Morgan's NPI, 1407835184, was assigned on January 11, 2006. Dr. Morgan graduated from USF Health Morsani College of Medicine in 1989. Dr. Morgan holds Florida license ME59018.

Dr. Morgan's primary practice is OnePath Diagnostics, at 6800 Southpoint Pkwy, Suite 950, Jacksonville, FL 32216. The practice phone is (904) 648-8600.

Dr. Morgan's primary practice is OnePath Diagnostics in Jacksonville, Florida. The medical group on file is Dermatology Specialists of Florida. Dmand AI also links Dr. Morgan to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Morgan's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morgan practices, 3 sites in all. Vendor and product names are available with a free account.

Pathology is Dr. Morgan's primary specialty in the NPI Registry, under taxonomy code 207ZD0900X. The record also lists dermatopathology. Dr. Morgan is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Morgan's licenses on file in 15 states: Florida, Delaware, Arizona, Colorado, Montana, Nevada, Texas, Alaska, Arkansas, Iowa, Illinois, Kentucky, Maine, Michigan and Missouri.

CMS data shows 17,022 Medicare services from Dr. Morgan across 8 procedure codes in 2024, for 7,090 Medicare patients. Medicare paid $727,977 for them. Every service was in an office.

CMS counts 7,090 Medicare patients who saw Dr. Morgan in 2024. The largest group is 65 to 74, with 3,271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morgan's median patient age at 68, with 50% women.

In 2023, Dr. Morgan wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $20 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Morgan for performance year 2024, reported as part of a group. Dr. Morgan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 131 papers to Dr. Morgan, published from 2005 to 2023. 2005 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Immunohistochemistry and Diagnosis, Differential. Dr. Morgan has published most often in J Cutan Pathol. Dr. Morgan's most frequent co-authors are Scott M. Schlauder, MD, MS, Farah Khan Khalil, MD and Sadia Saeed, MD.

CMS Open Payments shows 18 general payments to Dr. Morgan from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $142.

Dr. Morgan graduated from USF Health Morsani College of Medicine in 1989.

Dr. Morgan is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.